Valuation Guizhou Bailing Group Pharmaceutical Co., Ltd.

Stocks

End-of-day quote Shenzhen S.E. 2026-10-23			5-day change	1st Jan Change
4.600 ^CNY	-0.22%		+1.77%	+5.75%

10-23	Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026	CI
09-17	Guizhou Bailing Unit Gets China Regulator's Nod to Trial Tangning Tongluo Cream	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	11,050	10,622	11,404	11,236	5,255	5,938
Change	-	-3.87%	7.37%	-1.47%	-53.23%	12.99%
Enterprise Value (EV) ¹	12,306	11,871	12,339	12,505	6,656	6,812
Change	-	-3.53%	3.94%	1.34%	-46.78%	2.36%
P/E	71.2x	84.4x	81.6x	-27x	193x	-54.4x
PBR	2.84x	2.69x	2.85x	3.2x	1.65x	1.88x
PEG	-	-4.6x	7.3x	0x	-2x	0x
Capitalization / Revenue	3.58x	3.41x	3.22x	2.64x	1.37x	1.95x
EV / Revenue	3.99x	3.82x	3.49x	2.93x	1.74x	2.23x
EV / EBITDA	42.1x	36.6x	40.4x	-41.9x	53.6x	30.7x
EV / EBIT	62.6x	51.7x	60.8x	-31.1x	339x	63.1x
EV / FCF	45x	76.4x	27.3x	101x	62.4x	12.1x
FCF Yield	2.22%	1.31%	3.66%	0.99%	1.6%	8.26%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	0.11	0.09	0.1	-0.3	0.02	-0.08
Distribution rate	-	-	-	-	-	-
Net sales ¹	3,088	3,112	3,540	4,263	3,825	3,049
EBITDA ¹	292.4	324.2	305.6	-298.6	124.1	221.9
EBIT ¹	196.5	229.5	203	-402.3	19.62	108
Net income ¹	152.4	124.2	138.2	-414.5	33.62	-104.4
Net Debt ¹	1,256	1,249	935	1,268	1,400	874.7
Reference price ²	7.830	7.600	8.160	8.110	3.850	4.350
Nbr of stocks (in thousands)	1,411,200	1,397,598	1,397,598	1,385,502	1,365,010	1,365,010
Announcement Date	4/29/21	4/22/22	4/28/23	4/29/24	4/28/25	4/27/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GUIZHOU BAILING GROUP PHARMACEUTICAL CO., LTD.	-	-	-	-	941M
ELI LILLY AND COMPANY	37.06x	13.1x	27.8x	0.54%	1,135B
JOHNSON & JOHNSON	38.61x	6.49x	18.27x	2.02%	635B
ABBVIE INC.	36.46x	8.38x	17.29x	2.41%	505B
ROCHE HOLDING AG	20.87x	5.11x	12.73x	2.56%	378B
MERCK & CO., INC.	105.89x	5.92x	25.41x	2.34%	358B
NOVARTIS AG	21.76x	5.68x	13.94x	2.81%	295B
ASTRAZENECA PLC	22.43x	4.53x	12.94x	1.95%	266B
AMGEN INC.	27.87x	7.16x	12.81x	2.3%	237B
GILEAD SCIENCES, INC.	-45.48x	6.98x	27.06x	2.11%	193B
Average	29.50x	7.04x	18.69x	2.12%	400.46B
Weighted average by Cap.	35.23x	8.29x	20.39x	1.8%